by David Rosenbaum | Mar 17, 2020 | Uncategorized
Disasters and protests tend to bring out opportunists who attempt to capitalize on a popular term or rallying cry. This often ends in trademark applicants burning money on trademark applications that will likely end in both rejection by the United States Patent and...
by David Rosenbaum | Jan 15, 2020 | Uncategorized
By James Heracklis Blockchain Patentability Background Since blockchain technology was created in 2008 by the founder of Bitcoin, Satoshi Nakamoto, it has been difficult for the patent community to understand how to best handle blockchain innovations. The algorithms...
by David Rosenbaum | Aug 5, 2019 | Uncategorized
By: Adam Baechler Effective August 3, 2019, the United States Patent and Trademark Office (USPTO) enacted a new rule requiring all foreign trademark applicants and registrants be represented by a U.S. licensed attorney.[1] Foreign trademark applicants and registrants...
by davidweb1 | Jul 4, 2017 | PATENT, PATENT PROSECUTION, Uncategorized
FeSSIF/FaSSIF Dissolution: If you Understand What is Written Above You Should Read this Article A part of any complete study for a pre-clinical candidate (PCC) pharmaceutical compound is a dissolution study in Fed and Fasted Simulated Stomach and Intestinal Fluids...
by davidweb1 | Jul 4, 2017 | PATENT INFRINGEMENT, Uncategorized
Phase III Biosimilar Clinical Trial & Infringement Threat does not Create Justiciable Case or Controversy: Biosimilars will require the Patent Dance In Sandoz Inc. v. Amgen Inc., the Federal Circuit upheld the district court decision dismissing Sandoz’s...
by davidweb1 | Jul 4, 2017 | EXAMINATION GUIDELINES, PATENT, PATENT PROSECUTION, Uncategorized
USPTO Issues New & Revised Guidance on Patent Eligibility Under 35 USC § 101 The United States Patent and Trademark Office (USPTO) has issued revised guidance to its examiners relating to determination of patent eligibility under 35 U.S.C. §101. This “Interim...
